Top Glove Corporation Bhd
Change company Symbol lookup
Select an option...
TGLVY Top Glove Corporation Bhd
ACQRU Independence Holdings Corp
KEGS 1812 Brewing Company Inc
PHUN Phunware Inc
WFC Wells Fargo & Co
XRX Xerox Holdings Corp
BIDU Baidu Inc
CDRO Codere Online Luxembourg SA
AMZN Amazon.com Inc
LYFT Lyft Inc
Go


Based in Malaysia
Company profile

Top Glove Corporation Bhd. is a Malaysia-based manufacturer of gloves. The Company's segments include Malaysia, Thailand and China. It offers a product range, which includes a non-glove segment comprising condoms, face masks, dental dams, exercise bands and household products, fulfilling demand in both the healthcare and non-healthcare segment. Its gloves product categories include medical, surgical procedure, food and services, cleanroom, and safety and industrial. Its non gloves product categories include medical care, personal care, oral care, home care and industrial care. The Company has manufacturing operations in Malaysia, Thailand, Vietnam and China. Its subsidiaries include Top Glove Sdn Bhd, Eastern Press Sdn Bhd, TG Healthcare Sdn Bhd, TG Medical (U.S.A.), Inc, TG Worldwide Sdn Bhd and Top Glove Engineering Sdn Bhd, among others.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Price
Delayed
$0.768
Day's Change
0.0225 (3.02%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.768
Day's Low
0.7326
Volume
(Heavy Day)

Today's volume of 1,226 shares is on pace to be much greater than TGLVY's 10-day average volume of 4,816 shares.

1,226

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Barclays PLC (BCS) Investors

11:30 am ET September 27, 2022 (BusinessWire) Print

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Barclays PLC ("Barclays" or the "Company") (NYSE: BCS) American Depositary Receipts ("ADRs") between February 18, 2021 to March 25, 2022, inclusive (the "Class Period"). Barclays investors have until November 22, 2022 to file a lead plaintiff motion.

If you are a shareholder who suffered a loss, click here to participate.

On March 28, 2022, Barclays disclosed that its subsidiary, Barclays Bank PLC ("BBPLC") had issued approximately $15.2 billion in unregistered securities under an August 2019 shelf registration, and that it would commence a rescission offer for those unregistered securities, expecting the losses to be approximately £450 million.

On this news, Barclays' stock fell $0.96, or 10.6%, to close at $8.09 per ADR on March 28, 2022, thereby injuring investors.

Then, on July 28, 2022, Barclays issued interim financial results, announcing that BBPLC had also overissued unregistered securities under a second shelf registration statement. The Company disclosed that it had provision approximately $1.9 billion "related to the overissuance of structured notes" and approximately $201 million "related to liabilities that could be incurred arising out of ongoing discussion in respect of a potential SEC resolution."

On this news, Barclays' stock fell $0.41, or 5.2%, to close at $7.48 per ADR on July 28, 2022, thereby injuring investors further.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Barclays had a material weakness in its internal control environment due to the fact that the over-issuance had occurred and was not immediately identified; (2) BBPLC had and was selling unregistered securities in excess of the amounts registered by the August 2019 Shelf Registration Statement, (3) BBPLC was required to conduct a recission offer for those unregistered securities, and (4) BBPLC was violating U.S. securities laws and/or SEC regulations, subjecting Barclays to legal liability; and (5) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased Barclays securities during the Class Period, you may move the Court no later than November 22, 2022 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you purchased Barclays securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220927005413/en/

SOURCE: The Law Offices of Frank R. Cruz">

The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com 
www.frankcruzlaw.com
comtex tracking

COMTEX_415400365/1006/2022-09-27T11:30:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.